EyePoint Pharmaceuticals
EYPT
#5225
Rank
S$1.91 B
Marketcap
S$23.12
Share price
0.45%
Change (1 day)
94.80%
Change (1 year)

EyePoint Pharmaceuticals (EYPT) - Net assets

Net assets on the balance sheet as of September 2025 : S$0.25 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company has S$0.25 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

EyePoint Pharmaceuticals - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$0.45 B30.04%
2023-12-31$S$0.35 B172.26%
2022-12-31$S$0.12 B-48.17%
2021-12-31$S$0.24 B916.22%
2020-12-31$S$24.52 M118.41%
2019-12-31$S$11.23 M
2018-06-30$S$15.92 M-13.24%
2017-06-30$S$18.35 M-34.74%
2016-06-30$S$28.12 M-10.66%
2015-06-30$S$31.48 M69.23%
2014-06-30$S$18.6 M90.41%
2013-06-30$S$9.77 M-43.45%
2012-06-30$S$17.27 M-62.39%
2011-06-30$S$45.93 M0.12%
2010-06-30$S$45.88 M34.92%
2009-06-30$S$34 M-16.92%
2008-06-30$S$40.93 M-68.06%
2007-06-30$S$0.12 B-38.04%
2006-06-30$S$0.20 B101.85%
2005-06-30$S$0.10 B123.86%
2004-06-30$S$45.77 M516.07%
2003-06-30$S$7.43 M
2001-06-30$S$8.33 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NRC Health
NRC
S$18.57 M-92.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-S$3.74 Million-101.44% Bahamas